QuantiFERON testing for cell-mediated immunity to cytomegalovirus in patients with rheumatoid arthritis receiving abatacept and other DMARD therapy

Clin Rheumatol. 2013 Nov;32(11):1657-9. doi: 10.1007/s10067-013-2298-z. Epub 2013 Jun 11.

Authors

Anthony S Russell¹, Luiz Lisboa, Marla F Dos Santos, Deepali Kumar, Atul Humar

Affiliation

¹ University of Alberta, 562 Heritage Medical Centre, Edmonton, T6G 2S2, Canada, as.russell@ualberta.ca.

PMID: 23754242
DOI: 10.1007/s10067-013-2298-z

No abstract available

MeSH terms

Abatacept
Adult
Aged
Aged, 80 and over
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy
Arthritis, Rheumatoid / immunology*
Cytomegalovirus / immunology*
Female
Humans
Immunity, Cellular*
Immunoconjugates / therapeutic use*
Male
Middle Aged

Substances

Antirheumatic Agents
Immunoconjugates
Abatacept